BACKGROUND
HCFA has made considerable progress in becoming a value-based purchaser of health care by aggressively pursuing high quality care for beneficiaries at a reasonable cost. On behalf of the Medicare beneficiaries, HCFA is the direct purchaser of health care through the traditional fee-forservice program. Through the Medicare + Choice (M+C) program, HCFA purchases health care through contractors that manage the delivery of health care. Valuebased purchasing includes several strategies directed at improving the quality of care, encouraging the efficient use of resources, and providing information to beneficiaries to assist them in making choices. Performance measurement is a critical component for all of these purchasing strategies. Performance measures or indicators are used to formulate strategies, assure accountability and validate results. For purchasing policy, performance has come to mean how a plan or provider is functioning with regard to specific standards, benchmarks, or measures. The measures are often indicators of value, quality, or both. Thus, the key to performance measurement is to have adequate, valid and measurable indicators of the quality of health care provided.
In order to operationalize this concept of quality, through value-based purchasing, several measurement dimensions can be used:
• Structure measures that indicate the potential that appropriate services provided by experienced providers will be available when needed by patients.
• Process measures that indicate the degree to which services are available and provided according to best evidence available and needs of patients.
• Consumer experience and acceptabilitythe degree to which patients are satisfied with their care.
• Outcomes as indicators of actual change in health status and functioning. In measuring quality, it is important to account for a number of perspectives relevant to health care; including the purchaser, the patient, and the provider. Since the purchaser acts on behalf of the patient, there should be a substantial overlap between measures relevant to each, such as processes of care, satisfaction with care, and outcomes. Purchasers, however, must also be interested in a more extensive set of indicators that may affect cost, quality, continuity, coordination, and stability of care. For the M+C program, these include measures of benefit change, marketing materials, disenrollment practices, financial stability, and accreditation.
Thus, a full set of quality indicators might include measures of: structure, clinical performance, process of care, experience and satisfaction with care, patient outcomes, disenrollment, benefits and patient costs, plan characteristics (financial measures, staff and facility characteristics), compliance with contract requirements, and complaints and grievances.
While defining performance measurement is important, it is even more critical to characterize it in terms of various related activities that a purchaser might implement using performance measures. These include:
• Purchasing activities including aggressive contracting and quality-related pricing and bidding.
• Monitoring-continuous examination of particular performance measures to address potential problems and allocate limited resources for intervention; measures may include disenrollment, financial stability, access problems, appeals and grievances, and provider turnover.
• Quality improvement initiatives activities based on performance measures that are targeted to improving quality for particular patients or disease conditions. • Quality standards using performance measures to set standards that must be met by participating plans and providers.
• Developing a beneficiary information framework for presenting performance measures to beneficiaries to assist their choices among health plans and providers.
To support purchasing strategies for the M+C program, HCFA has made substantial progress in collecting the full range of performance measures. These measures are developed from data collected directly health plans, from surveys of beneficiaries, and from HCFA's administrative data. These data include managed care plan characteristics, the Health Plan Employer Data and Information Set (HEDIS ® ), the Consumer Assessment of Health Plans Sur vey (CAHPS ® ), health outcomes (Medicare Health Outcomes Sur vey), appeals data (CHDR and State fair hearing), desenrollment data, and benefits and copayments data. As part of developing risk-adjusted payment rates for managed care plans, HCFA and some States have also begun collecting encounter data which will also support performance measurement.
Perhaps the greatest, immediate challenge for HCFA is developing the methods to use performance data appropriately. While considerable work has been done on developing particular measures and collection efforts, very little is known on how to use various measures, either alone or in conjunction with each other, to reflect quality or performance from varying perspectives. How would we use these measures for pricing strategies? What if beneficiary satisfaction is not well correlated with process indicators of quality or with outcomes? Which measures are useful for informing beneficiary choices versus other purchasing strategies? Answering these and other important questions will be critical to using performance data for purchasing, monitoring, and beneficiary information efforts.
FUTURE OF PLAN PERFORMANCE MEASUREMENT
In an attempt to address several of these questions, HCFA contracted with the 
PAPERS
Ten papers on performance measurement that were either commissioned for the conference or were developed subsequent to the conference to refine or expand on conference themes are presented in this issue of the Review. Each of the papers reflects material presented at one or more of the sessions: history and evolution of performance measurement, designing measures to meet purchaser needs, performance measurement of vulnerable populations, data issues, and reporting. The papers are developed from various sources of information including the peer review published literature, documents created as deliverables in government contracts, other conference presentations, and organizational experience.
To begin, McIntyre, Rogers, and Heier provide an overview of health care performance measurement, including a chronological history of the major developments in the performance measurement field from Codman to Donabedian to HEDIS ® . Lied and Sheingold show how performance measurement is improved by integrating access, effectiveness of care, beneficiary experience, health status, and risk measures into an analytic framework. From the perspective of purchasers, Zema and Rogers explore how the results of performance measurement initiatives are used, and they examine how purchasers interact and share information. Ginsberg and Sheridan consider the effects of the large health care purchasing environment and employers' quality improvement activities on their use of data. Docteur describes the challenges to measuring quality of care in different settings, while Chawla, Hatzman, and Long discuss measures available for assessing performance in drug management programs. Cox examines differences in health care performance ratings between selected subgroups of the Medicare population. Goldstein, Cleary, Langwell, Zaslavsky, and Heller describe the CAHPS ® survey, a "tool" for performance improvement. A new adjustment model for CAHPS ® is presented by Zaslavsky, Zaborski, Ding, Shaul, Cioffi, and Cleary. Finally, McCall, Harlow, and Dayhoff evaluate the feasibility of developing hospitalization rates for ambulatory sensitive conditions for the M+C program.
CONCLUSION
The development of a research agenda, subsequent to the conference, addressed issues identified at the conference and at site visits to major purchasers of health care undertaken prior to the conference. The research agenda topics that were an outgrowth of this conference were:
• 
